Basil Lui
The East-West Bio Brief
Follow The East-West Bio Brief across the charts and keep up with new listener reviews. Get the updates in your inbox.
Track this podcast ยท 7 days freeCard required. Cancel anytime. Choose your plan at signup.
Over half of global biotech licensing value now comes from China, and the first signal usually shows up in Chinese. Every Monday, Basil Lui and Ning read those primary sources in the original and turn them into what matters for deals: who's licensing what, how much is real upfront cash, and where the next wave is coming from across Hong Kong, Singapore, Korea, Japan and Southeast Asia. Sharp, sourced and under fifteen minutes. Built for BD teams, VCs, crossover funds and family offices. Personal views, not investment advice.
Basil Lui
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.